India clears first dengue vaccine for people aged 4 to 60
India has approved its first dengue vaccine, marking an important milestone in the country’s efforts to tackle the mosquito-borne disease. The Central Drugs Standard Control Organisation (CDSCO) has granted approval to Japanese pharmaceutical company Takeda’s dengue vaccine, QDENGA (TAK-003), for individuals between the ages of 4 and 60. Takeda said the vaccine is now authorised in 43 countries and that… Continue reading "India clears first dengue vaccine for people aged 4 to 60"